Guggenheim Capital LLC reduced its holdings in Clorox Co (NYSE:CLX) by 0.8% during the fourth quarter, Holdings Channel reports. The fund owned 469,627 shares of the company’s stock after selling 3,800 shares during the quarter. Guggenheim Capital LLC’s holdings in Clorox were worth $69,852,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in CLX. Victory Capital Management Inc. increased its stake in Clorox by 18.5% in the 3rd quarter. Victory Capital Management Inc. now owns 23,010 shares of the company’s stock worth $3,035,000 after acquiring an additional 3,596 shares during the last quarter. Dupont Capital Management Corp bought a new position in Clorox in the 3rd quarter worth about $199,000. State of Wisconsin Investment Board increased its stake in Clorox by 490.9% in the 3rd quarter. State of Wisconsin Investment Board now owns 51,513 shares of the company’s stock worth $6,795,000 after acquiring an additional 42,796 shares during the last quarter. Candriam Luxembourg S.C.A. boosted its holdings in shares of Clorox by 4.0% in the 3rd quarter. Candriam Luxembourg S.C.A. now owns 10,599 shares of the company’s stock worth $1,398,000 after purchasing an additional 403 shares in the last quarter. Finally, Jennison Associates LLC boosted its holdings in shares of Clorox by 1.5% in the 3rd quarter. Jennison Associates LLC now owns 311,251 shares of the company’s stock worth $41,057,000 after purchasing an additional 4,551 shares in the last quarter. Institutional investors and hedge funds own 75.77% of the company’s stock.
CLX has been the subject of a number of research reports. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $163.00 price objective for the company in a report on Monday, January 8th. BMO Capital Markets set a $147.00 price objective on Clorox and gave the stock a “buy” rating in a report on Monday, February 5th. Morgan Stanley cut their price objective on Clorox from $140.00 to $133.00 and set an “equal weight” rating for the company in a report on Monday, February 5th. Jefferies Group reiterated a “hold” rating and issued a $148.00 price objective on shares of Clorox in a report on Thursday, January 4th. Finally, Wells Fargo & Co reiterated a “hold” rating and issued a $130.00 price objective on shares of Clorox in a report on Wednesday, December 13th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $132.46.
Clorox (NYSE:CLX) last issued its earnings results on Friday, February 2nd. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. Clorox’s quarterly revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.14 EPS. equities analysts predict that Clorox Co will post 6.23 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, May 11th. Investors of record on Wednesday, April 25th will be issued a dividend of $0.96 per share. The ex-dividend date is Tuesday, April 24th. This is a boost from Clorox’s previous quarterly dividend of $0.84. This represents a $3.84 annualized dividend and a yield of 2.95%. Clorox’s dividend payout ratio is currently 55.45%.
WARNING: This report was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://sportsperspectives.com/2018/03/13/clorox-co-clx-shares-sold-by-guggenheim-capital-llc.html.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.